A series of toxicity trials was conducted to analyze the acute and subchronic
oral toxicity of calcium from Jeju Lava Seawater (CJLS) in Sprague-Dawley rats.
In the acute toxicity trial, rats were administered 0 or a daily dose of 2,000
mg/kg body weight (BW) of CJLS. General behavior, side effects, and mortality
were monitored over 14 days. In the subacute and subchronic trials, daily doses
of 0, 250, 500, or 1,000 mg/kg BW were administered to the rats over 28 and 90
days, respectively. Clinical signs were examined daily, and changes in body
weight, relative organ weight (ROW), and hematological, biochemical, and
pathological parameters were recorded. The acute toxicity trial showed that the
maximum tolerated dose of CJLS was >2,000 mg/kg BW, with no adverse
effects or mortality observed during the 14-day period. In subacute and
subchronic trials, oral administration of CJLS at a dosage of 1,000 mg/kg BW/day
did not result in significant changes in BW, ROW, or hematological and
biochemical biomarkers. These results indicate that the oral administration of
CJLS at doses lower than 1,000 mg/kg BW/day is safe for rats, providing a basis
for the clinical use of CJLS.